Sei Investments Co. Has $4.53 Million Stake in LifeStance Health Group, Inc. $LFST

Sei Investments Co. boosted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 39.1% during the 1st quarter, HoldingsChannel reports. The fund owned 711,589 shares of the company’s stock after buying an additional 200,041 shares during the quarter. Sei Investments Co.’s holdings in LifeStance Health Group were worth $4,533,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada increased its holdings in LifeStance Health Group by 63.4% in the 1st quarter. Royal Bank of Canada now owns 70,248 shares of the company’s stock valued at $468,000 after buying an additional 27,244 shares during the period. AQR Capital Management LLC boosted its position in shares of LifeStance Health Group by 223.0% during the 1st quarter. AQR Capital Management LLC now owns 51,500 shares of the company’s stock valued at $343,000 after acquiring an additional 35,554 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of LifeStance Health Group by 3.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 142,950 shares of the company’s stock valued at $952,000 after acquiring an additional 4,169 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in LifeStance Health Group by 1.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 615,652 shares of the company’s stock valued at $4,100,000 after acquiring an additional 11,331 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in LifeStance Health Group by 10.2% in the second quarter. JPMorgan Chase & Co. now owns 550,657 shares of the company’s stock valued at $2,847,000 after acquiring an additional 51,154 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

Insider Activity

In other LifeStance Health Group news, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the transaction, the director owned 23,310,115 shares in the company, valued at approximately $186,947,122.30. This represents a 20.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert Bessler sold 894,337 shares of LifeStance Health Group stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $10.13, for a total value of $9,059,633.81. Following the completion of the sale, the director directly owned 539,763 shares in the company, valued at approximately $5,467,799.19. This represents a 62.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 7,612,394 shares of company stock worth $62,938,451 over the last quarter. 3.50% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on LFST shares. Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. KeyCorp boosted their price target on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 25th. Weiss Ratings reiterated a “hold (c-)” rating on shares of LifeStance Health Group in a research note on Wednesday, May 27th. Finally, JPMorgan Chase & Co. lifted their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Thursday, May 14th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $11.50.

LifeStance Health Group Trading Up 1.1%

NASDAQ:LFST opened at $10.37 on Thursday. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.18. LifeStance Health Group, Inc. has a 1-year low of $3.81 and a 1-year high of $11.76. The firm has a market capitalization of $4.02 billion, a price-to-earnings ratio of 172.83 and a beta of 1.14. The business’s 50-day moving average price is $9.83 and its two-hundred day moving average price is $8.01.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.03. The company had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The company’s revenue for the quarter was up 21.2% compared to the same quarter last year. On average, equities analysts expect that LifeStance Health Group, Inc. will post 0.12 earnings per share for the current year.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.